121 related articles for article (PubMed ID: 38052369)
21. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
[TBL] [Abstract][Full Text] [Related]
22. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.
Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
[TBL] [Abstract][Full Text] [Related]
23. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
Morales F; Pérez P; Tapia JC; Lobos-González L; Herranz JM; Guevara F; de Santiago PR; Palacios E; Andaur R; Sagredo EA; Marcelain K; Armisén R
Gene; 2022 Apr; 819():146246. PubMed ID: 35122924
[TBL] [Abstract][Full Text] [Related]
24. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
[TBL] [Abstract][Full Text] [Related]
25. Wnt signaling in triple negative breast cancer is associated with metastasis.
Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
[TBL] [Abstract][Full Text] [Related]
26. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326
[TBL] [Abstract][Full Text] [Related]
27. RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.
Zhu L; Shi H; Li P; Zhang P
Ann Clin Lab Sci; 2023 Jan; 53(1):21-29. PubMed ID: 36889779
[TBL] [Abstract][Full Text] [Related]
28. Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.
Ryu WJ; Lee JD; Park JC; Cha PH; Cho YH; Kim JY; Sohn JH; Paik S; Choi KY
Exp Mol Med; 2020 May; 52(5):832-842. PubMed ID: 32457491
[TBL] [Abstract][Full Text] [Related]
29. HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer.
Liu Q; He L; Li S; Li F; Deng G; Huang X; Yang M; Xiao Y; Chen X; Ouyang Y; Chen J; Wu X; Wang X; Song L; Lin C
J Hematol Oncol; 2021 Jan; 14(1):6. PubMed ID: 33407765
[TBL] [Abstract][Full Text] [Related]
30. Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
Zou H; Luo J; Guo Y; Tong T; Liu Y; Chen Y; Xiao Y; Ye L; Zhu C; Deng L; Wang B; Pan Y; Li P
Cell Mol Life Sci; 2023 Jan; 80(2):41. PubMed ID: 36633714
[TBL] [Abstract][Full Text] [Related]
31. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
[TBL] [Abstract][Full Text] [Related]
32. The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer.
Wang W; Rana PS; Markovic V; Sossey-Alaoui K
Breast Cancer Res; 2023 Mar; 25(1):31. PubMed ID: 36949468
[TBL] [Abstract][Full Text] [Related]
33. Ophiopogonin D suppresses TGF-β1-mediated metastatic behavior of MDA-MB-231 breast carcinoma cells via regulating ITGB1/FAK/Src/AKT/β-catenin/MMP-9 signaling axis.
Zhu X; Wang K; Chen Y
Toxicol In Vitro; 2020 Dec; 69():104973. PubMed ID: 32818624
[TBL] [Abstract][Full Text] [Related]
34. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
[TBL] [Abstract][Full Text] [Related]
35. COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation.
Sato F; Sagara A; Tajima K; Miura S; Inaba K; Ando Y; Oku T; Murakami T; Kato Y; Yumoto T
Breast Cancer Res Treat; 2022 Jul; 194(2):243-256. PubMed ID: 35624176
[TBL] [Abstract][Full Text] [Related]
36. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y
Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298
[TBL] [Abstract][Full Text] [Related]
37. Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/ Wnt/β-catenin signaling axis.
Cheng Z; Yu R; Li L; Mu J; Gong Y; Wu F; Liu Y; Zhou X; Zeng X; Wu Y; Sun R; Xiang T
Cell Mol Life Sci; 2022 May; 79(5):280. PubMed ID: 35507080
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.
Weeks SE; Kammerud SC; Metge BJ; AlSheikh HA; Schneider DA; Chen D; Wei S; Mobley JA; Ojesina AI; Shevde LA; Samant RS
Cell Death Dis; 2021 Mar; 12(3):242. PubMed ID: 33664239
[TBL] [Abstract][Full Text] [Related]
39. MiR-296-3p inhibits cell proliferation by the SOX4-Wnt/βcatenin pathway in triple-negative breast cancer.
Tian D; Luo L; Wang T; Qiao J
J Biosci; 2021; 46():. PubMed ID: 34785625
[TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of Nek2B and β-catenin in triple negative breast cancer].
Yan WP; Shen HH; Ma WX; Wang ZY; Shang LF; Shen NN; Qi GY; Wei R; Zhang XQ; Wang C
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):424-429. PubMed ID: 32392924
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
